The global remote patient monitoring (RPM) market is estimated to be valued at $40 Billion in 2023, and is expected to grow ...

Eversense 365 is the world’s first and only one year CGM, which was approved by the United States (US) Food and Drug Administration in September of 2024 and launched across the country in October of ...

Glucotrack has successfully completed its first in-human clinical study for the first real-time, continuous blood glucose monitor (CBGM) placed in the subclavian vein.

A U.K. court has ruled against Abbott in a trademark infringement case the company had brought over the design of a rival ...

This CGM will track your body's response - Could personalised glucose data inform your body’s metabolism and performance?

This finding could mean that data from continuous glucose monitors can protect people from becoming blind or developing diabetic neuropathy. Monitoring how often individuals were in a safe blood-sugar ...

The global Diabetes Drugs Market size was valued at USD 84.65 billion in 2024 and is expected to be worth around USD 177.74 ...

We are home to the world-renowned CONTOUR® portfolio of blood glucose monitoring systems and the exclusive global distribution partner for the Eversense® Continuous Glucose Monitoring Systems ...

Germantown, Maryland Monday, February 10, 2025, 16:00 Hrs [IST] ...

Along the way, the Lexington teen crossed paths not only with Kendrick Lamar, but also Jay-Z, Samuel L. Jackson and Serena ...

Byram Healthcare, a leader in home-based care and part of the Owens & Minor (NYSE: OMI) family, recently launched ...